Visfatin

An elevated plasma level of visfatin increases the risk of myocardial infarction

Y. Yang, Li, Z., Tao, H. F., Qi, X. Y., Wang, W. L., Yang, L., Wang, H., and Xu, P., An elevated plasma level of visfatin increases the risk of myocardial infarction, vol. 13, pp. 8586-8595, 2014.

Visfatin, an adipocytokine involved in metabolic and immune disorders, plays an important role in the etiology of cardiovascular disease. Recent evidence has shown that an elevated plasma level of visfatin may increase the risk of myocardial infarction (MI), but individual published studies have shown inconclusive results. This study aimed to obtain a more precise estimate of the association between the plasma visfatin level and MI risk through a detailed meta-analysis of studies published in peer-reviewed journals.

Subscribe to Visfatin